Bench-to-bedside: Transforming scientific breakthroughs into clinical success
Scientific innovation has never been stronger, but translation has never been harder.
In this video, Andreas Lysandropoulous, M.D., Ph.D., Global Medical Head of Neuroscience and Ophthalmology, shares insights for biotechs on converting scientific breakthroughs into clinical success.
Related Insights
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
CTB Blog
EMA’s new pre-submission interactions model pilot: A fundamental shift toward submission readiness and predictable reviews
Sep 30, 2026
CTB Blog
Engage early, design once: turning early-phase trials into a program strategy
Sep 10, 2026
CTB Blog
Five Practical Strategies for Accelerating Early Phase Studies
Aug 19, 2026
Article
Reading current FDA and NMPA trends: What oncology tells us about the changing regulatory landscape
Jul 21, 2026
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
Blog
A Deep Dive into the Genetic Therapies Bootcamp at the ACMG 2026 Annual Meeting
Jun 23, 2026
CTB Blog
The essential role of translation in early phase neurology research
Jun 18, 2026
CTB Blog
Even when capital flows freely, biotechs benefit from efficiency
Mar 24, 2026
CTB Blog
5 ways to secure biotech funding in 2026
Mar 19, 2026
Article
Case study: Protecting Phase 2 obesity retention and study timelines
Mar 18, 2026
CTB Webinar
Extend your funding runway: How to maintain capital efficiency in an improving market
Mar 10, 2026
Related Insights
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
CTB Blog
EMA’s new pre-submission interactions model pilot: A fundamental shift toward submission readiness and predictable reviews
Sep 30, 2026
CTB Blog
Engage early, design once: turning early-phase trials into a program strategy
Sep 10, 2026
CTB Blog
Five Practical Strategies for Accelerating Early Phase Studies
Aug 19, 2026
Article
Reading current FDA and NMPA trends: What oncology tells us about the changing regulatory landscape
Jul 21, 2026
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
Blog
A Deep Dive into the Genetic Therapies Bootcamp at the ACMG 2026 Annual Meeting
Jun 23, 2026
CTB Blog
The essential role of translation in early phase neurology research
Jun 18, 2026
CTB Blog
Even when capital flows freely, biotechs benefit from efficiency
Mar 24, 2026
CTB Blog
5 ways to secure biotech funding in 2026
Mar 19, 2026
Article
Case study: Protecting Phase 2 obesity retention and study timelines
Mar 18, 2026
CTB Webinar
Extend your funding runway: How to maintain capital efficiency in an improving market
Mar 10, 2026